Arvinas (ARVN) Total Liabilities (2017 - 2026)

Arvinas (ARVN) recorded quarterly Total Liabilities of $260.7 million in Q1 2026, down 8.2% quarter-over-quarter from $284.0 million in Q4 2025, and down 23.55% on a YoY basis from $341.0 million in Q1 2025.

Arvinas (ARVN) Total Liabilities (2017 - 2026) Analysis & Trends

Arvinas' Total Liabilities history runs 10 years deep, the most recent figure standing at $260.7 million for Q1 2026.

  • In Q1 2026, Total Liabilities fell 23.55% year-over-year to $260.7 million; the TTM figure through Mar 2026 stood at $260.7 million (down 23.55% YoY), while the FY2025 annual figure was $284.0 million, down 46.38% from the prior year.
  • Total Liabilities was $260.7 million for Q1 2026 at Arvinas, down from $284.0 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $765.0 million in Q1 2022 to a low of $260.7 million in Q1 2026.
  • Historically, Total Liabilities has averaged $547.5 million across 5 years, with a median of $602.9 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Total Liabilities surged 1105.64% in 2022, then plunged 55.84% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $703.9 million in 2022, then dropped by 8.42% to $644.6 million in 2023, then retreated by 17.83% to $529.7 million in 2024, then slumped by 46.38% to $284.0 million in 2025, then fell by 8.2% to $260.7 million in 2026.
  • The last three Total Liabilities figures came in at $260.7 million (Q1 2026), $284.0 million (Q4 2025), and $279.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.74 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.48 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 731.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 10.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 19.51 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 943,068.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.12 Bn
9 Abivax 91.96 Bn 91.96 Bn - 137.56 Mn
10 Arvinas 492.16 Mn -122.74 Mn - 260.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 260.70 Mn
Dec 31, 2025 284.00 Mn
Sep 30, 2025 279.90 Mn
Jun 30, 2025 300.00 Mn
Mar 31, 2025 341.00 Mn
Dec 31, 2024 529.70 Mn
Sep 30, 2024 581.10 Mn
Jun 30, 2024 679.40 Mn
Mar 31, 2024 602.90 Mn
Dec 31, 2023 644.60 Mn
Sep 30, 2023 601.10 Mn
Jun 30, 2023 619.90 Mn
Mar 31, 2023 664.80 Mn
Dec 31, 2022 703.90 Mn
Sep 30, 2022 713.30 Mn
Jun 30, 2022 736.40 Mn
Mar 31, 2022 765.00 Mn
Dec 31, 2021 799.90 Mn
Sep 30, 2021 787.13 Mn
Jun 30, 2021 61.08 Mn